Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thiery

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer Chemotherapy and Pharmacology|April 1, 2014
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinomaA Thiery-Vuillemin, G Mouillet, T Nguyen Tan Hon, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy SettingL Mauge, L Phan, N Benhamouda, et al.
British Journal of Cancer|December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic studyB Royer, E Kalbacher, S Onteniente, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) studyF Carneiro, A Vinceneux, M Larroquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2017
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapyK Fizazi, A Ulys, L Sengeløv, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|July 25, 2022
Guidelines of the French Society of ENT (SFORL): Drug-induced sleep endoscopy in adult obstructive sleep apnea syndromeP-L Bastier, O Gallet de Santerre, S Bartier, et al.
ESMO Open|June 19, 2024
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS studyP Barthélémy, L Albigès, B Escudier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Chemotherapy and Pharmacology|April 1, 2014
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinomaA Thiery-Vuillemin, G Mouillet, T Nguyen Tan Hon, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON StudyP Barthelemy, A Thiery-Vuillemin, T Lebret, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2022
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy SettingL Mauge, L Phan, N Benhamouda, et al.
British Journal of Cancer|December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic studyB Royer, E Kalbacher, S Onteniente, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) studyF Carneiro, A Vinceneux, M Larroquette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2017
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapyK Fizazi, A Ulys, L Sengeløv, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|July 25, 2022
Guidelines of the French Society of ENT (SFORL): Drug-induced sleep endoscopy in adult obstructive sleep apnea syndromeP-L Bastier, O Gallet de Santerre, S Bartier, et al.
ESMO Open|June 19, 2024
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS studyP Barthélémy, L Albigès, B Escudier, et al.
Pageof 3